BioSpace News Archive

Gemini Therapeutics Announces Presentation at 2nd Annual Dry AMD Therapeutic Development Summit

Research labs performing Sanger sequencing can now use Promega chemistry on any capillary electrophoresis (CE) platform.

InflaRx N.V. (Nasdaq: IFRX), announced today that the German Ministry of Education and Research (“Bundesministerium für Bildung und Forschung“ or “BMBF“) and the German Ministry of Health (“Bundesministerium für Gesundheit” or “BMG”) have notified InflaRx that the Company has been awarded a grant of up to EUR 43.7 million to support the development of vilobelimab for the treatment of severely ill, mechanically ventilated COVID-19 patients.

Plus Therapeutics, Inc. today announced clearance of its Investigational New Drug (IND) application from the U.S. Food and Drug Administration (FDA) for Rhenium-186 NanoLiposome (186RNL) for the treatment of leptomeningeal metastases (LM).

Venus Concept Inc. today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market the Venus Freedom device in the United States.

Antios Therapeutics, Inc. and Assembly Biosciences, Inc. (Nasdaq: ASMB) today announced that the companies have entered into a clinical collaboration agreement to evaluate a triple combination treatment in patients with chronic hepatitis B virus (HBV) infection.

Statera Biopharma, Inc. announced today that it has received Institutional Review Board (IRB) approval to conduct a Phase 1 pilot study at Loma Linda University Health to evaluate STAT-205 as a treatment to mitigate SARS-CoV-2 progression, the virus that causes COVID-19.

Selux Diagnostics, Inc. today announced that it has received a $2.8 million award from the U.S. National Institutes of Health (NIH) to help the company commercialize its Next Generation ‘Phenotyping’ (NGP) platform for rapid antimicrobial susceptibility testing (AST).

LLR Partners today announced an investment in Genesee Scientific , a manufacturer and distributor of products to global life science markets.

9 Meters Biopharma, Inc. announced today that the company will deliver a poster presentation highlighting vurolenatide and will host a booth exhibit at the in-person component of the American College of Gastroenterology (ACG) 2021 Annual Scientific Meeting, held in a hybrid format both virtually and in Las Vegas, Nevada on October 22 - 27, 2021.